Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

被引：56

作者：

Boell, Boris ^{[1
]}

Borchmann, Peter ^{[1
]}

Topp, Max S. ^{[2
]}

Haenel, Mathias ^{[3
]}

Reiners, Katrin S. ^{[1
]}

Engert, Andreas ^{[1
]}

Naumann, Ralph ^{[4
]}

机构：

[1] Univ Hosp Cologne, German Hodgkin Study Grp, Cologne, Germany

[2] Univ Hosp Wuerzburg, Wurzburg, Germany

[3] Hosp Chemnitz, Chemnitz, Germany

[4] Stiftungsklinikum Mittelrhein Koblenz, Koblenz, Germany

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 148卷 / 03期

关键词：

Hodgkin lymphoma; IMIDs; thalidomide; lenalidomide; immunotherapy; CELL TRANSPLANTATION; PATHOGENESIS; THALIDOMIDE;

D O I：

10.1111/j.1365-2141.2009.07963.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：480 / 482

页数：3

共 10 条

[1] Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents [J].

Bartlett, JB ;

Dredge, K ;

Dalgleish, AG .

NATURE REVIEWS CANCER, 2004, 4 (04) :314-322

[2]

Cashen Amanda F, 2008, Clin Adv Hematol Oncol, V6, P517

[3] Lenalidomide for the treatment of B-cell malignancies [J].

Chanan-Khan, Asher A. ;

Cheson, Bruce D. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) :1544-1552

[4] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].

Cheson, BD ;

Horning, SJ ;

Coiffier, B ;

Shipp, MA ;

Fisher, RI ;

Connors, JM ;

Lister, TA ;

Vose, J ;

Grillo-López, A ;

Hagenbeek, A ;

Cabanillas, F ;

Klippensten, D ;

Hiddemann, W ;

Castellino, R ;

Harris, NL ;

Armitage, JO ;

Carter, W ;

Hoppe, R ;

Canellos, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253

[5] The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma [J].

Enblad, Gunila ;

Molin, Daniel ;

Glimelius, Ingrid ;

Fischer, Marie ;

Nilsson, Gunnar .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (05) :805-+

[6] Current strategies and new approaches in the treatment of Hodgkin's lymphoma [J].

Fuchs, Michael ;

Diehl, Volker ;

Re, Daniel .

PATHOBIOLOGY, 2006, 73 (03) :126-140

[7] Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review [J].

Laport, Ginna G. .

LEUKEMIA & LYMPHOMA, 2008, 49 (10) :1854-1859

[8] Immunotherapeutic and antitumour potential of thalidomide analogues [J].

Marriott, JB ;

Muller, G ;

Stirling, D ;

Dalgleish, AG .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (04) :675-682

[9] Molecular pathogenesis of Hodgkin's lymphoma [J].

Re, D ;

Küppers, R ;

Diehl, V .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6379-6386

[10] Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: An analysis from the lymphoma working party of the European group for blood and marrow transplantation [J].

Sureda, Anna ;

Robinson, Stephen ;

Canals, Carmen ;

Carella, Angela M. ;

Boogaerts, Marc A. ;

Caballero, Dolores ;

Hunter, Ann E. ;

Kanz, Lothar ;

Slavin, Shimon ;

Cornelisson, Jan J. ;

Gramatzki, Martin ;

Niederwieser, Dietger ;

Russell, Nigel H. ;

Schmitz, Norbert .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :455-462

← 1 →